Genentech, part of the Roche Group, shared encouraging two-year data from the ongoing RAINBOWFISH study at the 29th World Muscle Society Congress (October 8-12, 2024). This study evaluated the efficacy and safety of Evrysdi® (risdiplam) in children with spinal muscular…
Foundation Medicine, Inc. has announced FDA approval for FoundationOne® Liquid CDx as a companion diagnostic for Itovebi™ (inavolisib) when used with palbociclib (Ibrance®) and fulvestrant. This therapy, developed by Genentech, is designed for adult patients with endocrine-resistant, PIK3CA-mutated, hormone receptor-positive,…
Pfizer Inc. (NYSE: PFE) has announced that the U.S. Food and Drug Administration (FDA) has approved HYMPAVZI™ (marstacimab-hncq) for routine prophylaxis. This treatment is designed to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients aged…
Transverse Medical, Inc., known for its POINT-GUARD™ Cerebral Embolic Protection device, is excited to announce the appointment of Ian T. Meredith, MD, to its Board of Directors. With over 35 years of experience in cardiology, Professor Meredith has a proven…
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) announced the acceptance of six abstracts, including five poster presentations, at the American Society of Nephrology (ASN) Kidney Week 2024, happening in San Diego, CA from October 23-27. These findings emphasize the clinical significance of…
VISIE Inc., formerly Advanced Scanners, has successfully showcased Continuous Anatomic Auto Tracking (CAAT) for robotic-assisted total knee arthroplasty (RA-TKA) at its headquarters in Austin, TX. Continuous Anatomic Auto Tracking (CAAT) CAAT is a groundbreaking technology that enhances surgical robotic and…
Reproductive Medicine Associates (RMA), a leading provider in reproductive services and a pioneer in IVF research, proudly celebrated its 25th anniversary this month. Over the past quarter-century, RMA has made significant contributions to fertility preservation and infertility treatments, driving innovations…
Melt Pharmaceuticals, Inc., a clinical-stage company focused on innovative procedural sedation solutions, has announced the dosing of the last patient in its pivotal Phase 3 study of MELT-300, a non-IV, non-opioid tablet designed for procedural sedation during cataract surgery. MELT-300…
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company known for its UroShield®, PainShield®, and WoundShield® Surface Acoustic Wave (SAW) portable ultrasonic therapeutic devices, has announced a non-binding term sheet for a licensing and supply agreement with APOGEPHA Arzneimittel GmbH, a…
ŌURA, the maker of the Oura Ring, announced findings from a new sleep accuracy study published in the peer-reviewed journal Sensors and presented at Sleep Europe 2024. Conducted by researchers at Brigham and Women’s Hospital, the study evaluated the sleep-staging…
Paige, a leader in next-generation AI technology, has announced that its foundation models will be showcased by Microsoft at the HLTH 2024 conference in Las Vegas. On October 21st, Matt Lungren, MD and Chief Scientific Officer of Microsoft Health &…
Wysa, a global leader in AI-driven mental health support, has announced the launch of the Safety Assessment for LLMs in Mental Health (SAFE-LMH) initiative. Unveiled on World Mental Health Day, this groundbreaking initiative aims to create a unique platform for…